Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and use of a fibrinogen binding motif present in EFB and COA for therapeutics and vaccines against Staphylococcus aureus

Compositions and use of a fibrinogen binding motif present in EFB and COA for therapeutics and vaccines against Staphylococcus aureus

US Patent 11407819 · Granted Aug 9, 2022

Estimated economic value: $565,617,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CAR for use in the treatment of HvG disease2025
Fusion protein for use in the treatment of HVG disease2025
Prokaryotic collagen therapeutics for postoperative adhesions2024
Methods and compositions for adaptive immune modulation2023
Designer collagens and use thereof2023
Targeting of ligand binding sites in ClfA2022
Fusion protein for use in the treatment of HvG disease2021
Crystal structure of Staphylococcus aureus clumping factor A in complex with fib2021
Crystal structure of Staphylococcus aureus clumping factor A in complex with fib2021
Antigen binding protein against HER32021
Specific binding sites in collagen for integrins and use thereof2019
Designer collagens and use thereof2017